analyzeportfolio
Nasdaq · Financials

Cme Group Inc. (CME)

As-reported financials and SEC filings for Cme Group Inc. The latest annual period is FY2025. The latest reported quarter is Q3 FY2026. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.

About Cme Group Inc.

CME Group Inc. operates as a financial exchange company providing clearing and transaction services for various asset classes including interest rates, equities, foreign exchange, agricultural commodities, energy, and metals. It offers market data and information services to its clients, which include traders, investors, and financial institutions. The company facilitates trading and risk management through its electronic trading platforms and clearinghouses.

Snapshot

Revenue
$6.52B
Revenue growth (YoY)
6.4%
Net income
$4.07B
Diluted EPS
$11.16
Gross margin
—
Operating margin
64.9%
Net margin
62.5%
FCF margin
64.3%
ROE
14.2%
net income / fiscal-year-end equity
P/E
25.1×
trailing when available, otherwise FY EPS
Market cap
$109.42B
Long-term debt / equity
—
non-current term debt only

Fundamentals are from SEC filings for FY2025, the latest annual period (ended December 31, 2025). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.

What changed at Cme Group

  • Revenue grew 6.4% to $6.5B in FY2025, slower than the 9.9% the year before.
  • Operating margin is 64.9% in FY2025, +8.5 pp against 56.4% in FY2021.
  • Most recent quarter Q3 FY2026: revenue $1.7B, up 13.0% from Q3 FY2025.
  • Free cash flow was $4.2B in FY2025, 64.3% of revenue.
  • Net income rose 15.5% to $4.1B in FY2025.

Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.

Peer comparison

Where Cme Group’s fundamentals sit among the 425 Financials companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).

Operating margin64.9%
Highest of 141
Net margin62.5%
98th percentile of 372
FCF margin64.3%
95th percentile of 266
Revenue growth (YoY)+6.4%
35th percentile of 419
ROE14.2%
73rd percentile of 374
P/E25.1×
82nd percentile of 308
Short interest3.17d
41st percentile of 418

Cme Group’s operating margin of 64.9% is the highest of the 141 Financials companies reporting it. Cme Group’s net margin of 62.5% ranks in the 98th percentile of the 372 Financials companies reporting it. Cme Group’s FCF margin of 64.3% ranks in the 95th percentile of the 266 Financials companies reporting it.

1 reported insider purchase (code P) totaling $78,626 in the last 90 days, against 4 sales totaling $4.4M. For context, about 15% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →

Percentiles describe where a figure sits among sector peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.

Institutional ownership

Held by 5 of the superinvestors we track (plus 7 quant / multi-strat books), based on each investor’s most recent 13F; periods vary by investor (newest: Q2 2026).

Conviction investors
5
+7 quant / multi-strat
Initiated / added
10
2 new, 8 added
Reduced / exited
0
0 trimmed, 0 exited
Combined position
$2.42B
reported long value
InvestorAs ofPosition valueSharesChange
Two Sigma InvestmentsquantQ2 2026$534.4M2.4MAdded
AQR Capital ManagementquantQ2 2026$447.7M2.0MAdded
Citadel AdvisorsquantQ2 2026$332.4M1.5MAdded
D. E. ShawquantQ2 2026$292.2M1.3MAdded
Millennium ManagementquantQ2 2026$264.1M1.2MAdded
Point72 Asset ManagementquantQ2 2026$164.2M743.7KAdded
Renaissance TechnologiesquantQ2 2026$150.2M680.0KAdded
Baupost GroupQ2 2026$136.7M619.0KNew
Gotham Asset ManagementQ2 2026$44.3M200.6KAdded
Viking Global InvestorsQ2 2026$33.8M153.0KNew
Markel GroupQ2 2026$11.0M49.8KHeld
Soros Fund ManagementQ2 2026$6.6M30.0KHeld

From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.

Recent insider activity

Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4.

Buys (90d)
1
1 insider
Bought (90d)
$79K
code P value
Sells (90d)
4
$4.4M
Reported activity
Net selling
by $ value, 90d
Trade dateInsiderTypeSharesPriceValue
2026-10-22
Martin J. GepsmanDirectorSell400$302.50$121K
2026-09-25
filed 2026-09-28
William R. ShepardDirectorBuy293$268.76$79K
2026-09-14
Elizabeth A. CookDirectorSell500$280.11$140K
2026-09-10
filed 2026-09-11
Terrence A. DuffyChairman and CEOSell14.4K$274.41$3.9M
2026-09-10
filed 2026-09-11
Terrence A. DuffyChairman and CEOSell628$275.03$173K
2026-06-25
filed 2026-06-29
William R. ShepardDirectorBuy325$230.57$75K
2026-06-25
filed 2026-06-29
William R. ShepardDirectorBuy14$230.57$3K
2026-05-18
filed 2026-05-19
Hilda Harris PiellSr MD & Chief HR OfficerSell5.8K$304.63$1.8M
2026-05-15
filed 2026-05-18
Terrence A. DuffyChairman and CEOSell26.0K$298.14$7.8M
2026-05-15
filed 2026-05-18
Terrence A. DuffyChairman and CEOSell9.0K$299.58$2.7M

Reported non-derivative purchases and sales (codes P/S), which may be open-market or private. Excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.

Short interest

Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.

Shares short
5.5M
settled 2026-09-30
Change vs prior
-4.8%
vs previous settlement
Days to cover
3.17
at avg daily volume
Avg daily volume
1.7M
FINRA reported
SettlementShares shortChangeDays to cover
2026-09-305.5M-4.8%3.17
2026-09-155.8M+3.1%3.34
2026-08-315.6M+8.3%2.83
2026-08-145.2M-16.3%3.10
2026-07-316.2M+6.4%2.26
2026-07-155.8M-2.9%1.88
2026-06-306.0M+15.3%1.24
2026-06-155.2M+14.1%1.25

Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.

Income statement (as reported)

 FY2025FY2024FY2023FY2022FY2021
Revenue$6.52B$6.13B$5.58B$5.02B$4.69B
Gross profit—————
Operating income$4.23B$3.93B$3.44B$3.02B$2.65B
Pre-tax income$5.33B$4.54B$4.15B$3.49B$3.37B
Net income$4.07B$3.53B$3.23B$2.69B$2.64B
Diluted EPS$11.16$9.67$8.86$7.40$7.29

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures (free cash flow is operating cash flow minus capital expenditures, which can differ from a company’s own definition); “adj” means restated for a stock split (tap or hover a figure to see how it was calculated or what was filed). Diluted EPS includes discontinued operations where a company reports them. Cash & Equivalents excludes short-term investments and may include restricted cash where that is the figure the company tags. Full details: where the numbers come from.

Balance sheet (as reported)

 FY2025FY2024FY2023FY2022FY2021
Cash and equivalents$4.42B$2.89B$2.91B$2.72B$2.83B
Current assets$165.36B$103.03B$94.89B$139.08B$161.76B
Total assets$198.42B$137.45B$129.71B$174.18B$196.78B
Current liabilities$160.30B$102.31B$93.42B$137.69B$160.40B
Long-term debt—————
Total liabilities$169.70B$110.96B$102.97B$147.30B$169.38B
Total equity$28.73B$26.49B$26.74B$26.88B$27.40B

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures (free cash flow is operating cash flow minus capital expenditures, which can differ from a company’s own definition); “adj” means restated for a stock split (tap or hover a figure to see how it was calculated or what was filed). Diluted EPS includes discontinued operations where a company reports them. Cash & Equivalents excludes short-term investments and may include restricted cash where that is the figure the company tags. Full details: where the numbers come from.

Cash flow (as reported)

 FY2025FY2024FY2023FY2022FY2021
Operating cash flow$4.28B$3.69B$3.45B$3.06B$2.40B
Capital expenditure$83.5M$94.0M$76.4M$89.7M$127.2M
Free cash flow

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures (free cash flow is operating cash flow minus capital expenditures, which can differ from a company’s own definition); “adj” means restated for a stock split (tap or hover a figure to see how it was calculated or what was filed). Diluted EPS includes discontinued operations where a company reports them. Cash & Equivalents excludes short-term investments and may include restricted cash where that is the figure the company tags. Full details: where the numbers come from.

Quarterly trend

QuarterRevenueRevenue YoYNet incomeDiluted EPS
Q3 FY2026$1.74B13.0%$1.04B$2.89
Q2 FY2026$1.71B0.8%$1.04B$2.88
Q1 FY2026$1.88B14.5%$1.15B$3.18
Q4 FY20258.1%
Q3 FY2025$1.54B-3.0%$908.0M$2.49
Q2 FY2025$1.69B10.4%$1.03B$2.81
Q1 FY2025$1.64B10.4%$956.2M$2.62
Q4 FY20246.0%—

Latest 8 quarters, from company XBRL filings on SEC EDGAR. A dotted underline marks a fourth-quarter figure we calculated from the full year and the first nine months. Revenue YoY is our calculation too: each quarter against the same quarter a year earlier.

Company facts

ExchangeNasdaq
SectorFinancials
SIC industrySecurity & Commodity Brokers, Dealers, Exchanges & Services
Latest annual periodFY2025 (ended December 31, 2025)
Latest reported quarterQ3 FY2026 (ended September 30, 2026)
Oldest indexed filing2018
SEC CIK1156375

Selected SEC filings

10-K2026-02-26
View on EDGAR →
10-K2025-02-27
View on EDGAR →
10-Q2026-10-23
View on EDGAR →
10-Q2026-07-24
View on EDGAR →
10-Q2026-04-24
View on EDGAR →
10-Q2025-10-24
View on EDGAR →
8-K2026-10-21
View on EDGAR →
8-K2026-09-25
View on EDGAR →

Largest Financials peers

All Financials companies →

CME head to head

Monitor CME

Get an alert when Cme Group files something material, see which superinvestors own it, and ask its filings a question with cited answers.

Monitor CME free

Includes one free filing-grounded research answer. Or check your whole portfolio, no account needed.

Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.